Global to push GA events into
skip to main content

Title: Uses of monoclonial antibody 8H9

This invention provides an antibody that binds the same antigen as that of monoclonal antibody 8H9, wherein the heavy chain CDR (Complementary Determining Region)1 comprises NYDIN, heavy chain CDR2 comprises WIFPGDGSTQY, heavy chain CDR3 comprises QTTATWFAY, and the light chain CDR1 comprises RASQSISDYLH, light chain CDR2 comprises YASQSIS, and light chain CDR3 comprises QNGHSFPLT. In another embodiment, there is provided a polypeptide that binds the same antigen as that of monoclonal antibody 8H9, wherein the polypeptide comprises NYDIN, WIFPGDGSTQY, QTTATWFAY, RASQSISDYLH, YASQSIS, and QNGHSFPLT.
Inventors:
Issue Date:
OSTI Identifier:
1185299
Assignee:
Sloan-Kettering Institute for Cancer Research (New York, NY) CHO
Patent Number(s):
9,062,110
Application Number:
13/858,234
Contract Number:
FG02-93ER61658
Resource Relation:
Patent File Date: 2013 Apr 08
Research Org:
Sloan-Kettering Institute for Cancer Research, New York, NY (United States)
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES

Other works cited in this record:

Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice
journal, January 1995

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975
  • Köhler, G.; Milstein, C.
  • Nature, Vol. 256, Issue 5517, p. 495-497
  • DOI: 10.1038/256495a0

The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
journal, June 1991

Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts
journal, June 1984

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy
journal, June 1997

Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas
journal, August 1992

Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study
journal, August 1993

Biotechnological and gene therapeutic strategies in cancer treatment
journal, June 1995

Functional expression of chimeric receptor genes in human T cells
journal, February 2001

In vivo tracking of tumor-specific T cells
journal, April 2001
  • Yee, Cassian; Riddell, Stanley R.; Greenberg, Philip D.
  • Current Opinion in Immunology, Vol. 13, Issue 2, p. 141-146
  • DOI: 10.1016/S0952-7915(00)00196-5

The intergroup rhabdomyosarcoma study-II
journal, March 1993

Targeted radioimmunotherapy for leptomeningeal cancer using 131I-3F8
journal, January 2000

Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells
journal, November 1997

Immunocytokines: A Promising Approach to Cancer Immunotherapy
journal, December 1998

Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses
journal, January 1996

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma
journal, January 1995

Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones
journal, March 2000
  • Chen, Shaohua; Caragine, Theresa; Cheung, Nai-Kong V.
  • The American Journal of Pathology, Vol. 156, Issue 3, p. 1085-1091
  • DOI: 10.1016/S0002-9440(10)64976-0

Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations
journal, April 1997

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors
journal, November 1999

Similar records in DOepatents and OSTI.GOV collections: